|
1
|
Park JW, Chen M, Colombo M, Roberts LR,
Schwartz M, Chen PJ, Kudo M, Johnson P, Wagner S, Orsini LS and
Sherman M: Global patterns of hepatocellular carcinoma management
from diagnosis to death: The BRIDGE Study. Liver Int. 35:2155–2166.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Toffanin S, Hoshida Y, Lachenmayer A,
Villanueva A, Cabellos L, Minguez B, Savic R, Ward SC, Thung S,
Chiang DY, et al: MicroRNA-based classification of hepatocellular
carcinoma and oncogenic role of miR-517a. Gastroenterology.
140:1618–1628.e16. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang G, Lau WY, Wang ZG, Pan ZY, Yuan SX,
Shen F, Zhou WP and Wu MC: Antiviral therapy improves postoperative
survival in patients with hepatocellular carcinoma: A randomized
controlled trial. Ann Surg. 261:56–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoshida Y, Toffanin S, Lachenmayer A,
Villanueva A, Minguez B and Llovet JM: Molecular classification and
novel targets in hepatocellular carcinoma: Recent advancements.
Semin Liver Dis. 30:35–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tovar V, Alsinet C, Villanueva A, Hoshida
Y, Chiang DY, Solé M, Thung S, Moyano S, Toffanin S, Mínguez B, et
al: IGF activation in a molecular subclass of hepatocellular
carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol.
52:550–559. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Villanueva A, Chiang DY, Newell P, Peix J,
Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, et al:
Pivotal role of mTOR signaling in hepatocellular carcinoma.
Gastroenterology. 135:1972–1983, e1-e11. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cai Y, Yu X, Hu S and Yu J: A brief review
on the mechanisms of miRNA regulation. Genomics Proteomics
Bioinformatics. 7:147–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang YQ, Ren YF, Song YJ, Xue YF, Zhang
XJ, Cao ST, Deng ZJ, Wu J, Chen L, Li G, et al: MicroRNA-581
promotes hepatitis B virus surface antigen expression by targeting
Dicer and EDEM1. Carcinogenesis. 35:2127–2133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Su X, Wang H, Ge W, Yang M, Hou J, Chen T,
Li N and Cao X: An in vivo method to identify microRNA targets not
predicted by computation algorithms: p21 targeting by miR-92a in
cancer. Cancer Res. 75:2875–2885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shih YT, Wang MC, Zhou J, Peng HH, Lee DY
and Chiu JJ: Endothelial progenitors promote hepatocarcinoma
intrahepatic metastasis through monocyte chemotactic protein-1
induction of microRNA-21. Gut. 64:1132–1147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cui W, Huang Z, He H, Gu N, Qin G, Lv J,
Zheng T, Sugimoto K and Wu Q: MiR-1188 at the imprinted Dlk1-Dio3
domain acts as a tumor suppressor in hepatoma cells. Mol Biol Cell.
26:1416–1427. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Q, Xu Y, Wei S, Gao W, Chen L, Zhou T,
Wang Z, Ying M and Zheng Q: miRNA-148b suppresses hepatic cancer
stem cell by targeting neuropilin-1. Biosci Rep. 35:e002292015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang X, Zhang XF, Lu X, Jia HL, Liang L,
Dong QZ, Ye QH and Qin LX: MicroRNA-26a suppresses angiogenesis in
human hepatocellular carcinoma by targeting hepatocyte growth
factor-cMet pathway. Hepatology. 59:1874–1885. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J,
Qin Y, Sun Z and Zheng X: miR-183 inhibits TGF-beta1-induced
apoptosis by downregulation of PDCD4 expression in human
hepatocellular carcinoma cells. BMC Cancer. 10:3542010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y,
Jia WH and Zhuang SM: Effects of microRNA-29 on apoptosis,
tumorigenicity, and prognosis of hepatocellular carcinoma.
Hepatology. 51:836–845. 2010.PubMed/NCBI
|
|
17
|
Coulouarn C, Factor VM, Andersen JB,
Durkin ME and Thorgeirsson SS: Loss of miR-122 expression in liver
cancer correlates with suppression of the hepatic phenotype and
gain of metastatic properties. Oncogene. 28:3526–3536. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Viswanathan SR, Powers JT, Einhorn W,
Hoshida Y, Ng TL, Toffanin S, O'Sullivan M, Lu J, Phillips LA,
Lockhart VL, et al: Lin28 promotes transformation and is associated
with advanced human malignancies. Nat Genet. 41:843–848. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chung JY and Hewitt SM: An optimized RNA
extraction method from archival formalin-fixed paraffin-embedded
tissue. Methods Mol Biol. 611:19–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43:(Database Issue). D146–D152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lim EL, Trinh DL, Scott DW, Chu A,
Krzywinski M, Zhao Y, Robertson AG, Mungall AJ, Schein J, Boyle M,
et al: Comprehensive miRNA sequence analysis reveals survival
differences in diffuse large B-cell lymphoma patients. Genome Biol.
16:182015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Y, Xing Y, Liang C, Hu L, Xu F and
Chen Y: Crucial microRNAs and genes of human primary breast cancer
explored by microRNA-mRNA integrated analysis. Tumour Biol.
36:5571–5579. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hata A and Kashima R: Dysregulation of
microRNA biogenesis machinery in cancer. Crit Rev Biochem Mol Biol.
51:121–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leonardo TR, Schultheisz HL, Loring JF and
Laurent LC: The functions of microRNAs in pluripotency and
reprogramming. Nat Cell Biol. 14:1114–1121. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martin H, Mali RS, Ma P, Chatterjee A,
Ramdas B, Sims E, Munugalavadla V, Ghosh J, Mattingly RR, Visconte
V, et al: Pak and Rac GTPases promote oncogenic KIT-induced
neoplasms. J Clin Invest. 123:4449–4463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Melzer J, Kraft KF, Urbach R and Raabe T:
The p21-activated kinase Mbt is a component of the apical protein
complex in central brain neuroblasts and controls cell
proliferation. Development. 140:1871–1881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gu J, Li K, Li M, Wu X, Zhang L, Ding Q,
Wu W, Yang J, Mu J, Wen H, et al: A role for p21-activated kinase 7
in the development of gastric cancer. FEBS J. 280:46–55. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang HH, Zhang ZY, Che CL, Mei YF and Shi
YZ: Array analysis for potential biomarker of gemcitabine
identification in non-small cell lung cancer cell lines. Int J Clin
Exp Pathol. 6:1734–1746. 2013.PubMed/NCBI
|
|
31
|
Xie Q, Chen X, Lu F, Zhang T, Hao M, Wang
Y, Zhao J, McCrae MA and Zhuang H: Aberrant expression of microRNA
155 may accelerate cell proliferation by targeting sex-determining
region Y box 6 in hepatocellular carcinoma. Cancer. 118:2431–2442.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Giroux V, Dagorn JC and Iovanna JL: A
review of kinases implicated in pancreatic cancer. Pancreatology.
9:738–754. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han K, Zhou Y, Gan ZH, Qi WX, Zhang JJ,
Fen T, Meng W, Jiang L, Shen Z and Min DL: p21-activated kinase 7
is an oncogene in human osteosarcoma. Cell Biol Int. 38:1394–1402.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wells CM and Jones GE: The emerging
importance of group II PAKs. Biochem J. 425:465–473. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tang YW: Transcriptomic approach predicts
tempo of disease progression in HIV-1 infections. Clin Chem.
59:1143–1144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu C, He X, Zheng Z, Zhang Z, Wei C, Guan
K, Hou L, Zhang B, Zhu L, Cao Y, et al: Downregulation of microRNA
miR-526a by enterovirus inhibits RIG-I-dependent innate immune
response. J Virol. 88:11356–11368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fu Y, Yi Z, Wu X, Li J and Xu F:
Circulating microRNAs in patients with active pulmonary
tuberculosis. J Clin Microbiol. 49:4246–4251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang ZY, Fu SL, Xu SQ, et al: By
downregulating Ku80, hsa-miR-526b suppresses non-small cell lung
cancer. Oncotarget. 6:1462–1477. 2015. View Article : Google Scholar : PubMed/NCBI
|
